BIOMAT Database Logo BIOMAT Database Logo

Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. 1994

N Loimer, and P Hofmann, and H R Chaudhry
Psychiatrische Universitätsklinik Wien, Austria.

Naloxone is used intravenously in opiate addiction in emergency cases, in rapid opiate detoxification, and as a diagnostic tool. This is a study comparing the efficacy of intranasal naloxone to other routes (intravenous/intramuscular) in 17 opiate-dependent patients. The nasal drug administration of naloxone was found to be as effective as the intravenous route. The nasal drug application offers a wide margin of safety for patients and medical staff, especially in emergency situations in regard to infection risks associated with vessel puncture.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009293 Opioid-Related Disorders Disorders related to or resulting from abuse or misuse of OPIOIDS. Opiate Addiction,Opiate Dependence,Opioid Misuse,Opioid Use Disorder,Prescription Opioid Abuse,Prescription Opioid Misuse,Addiction, Opioid,Dependence, Opioid,Opiate Abuse,Opioid Abuse,Opioid Addiction,Opioid Dependence,Abuse, Opiate,Abuse, Opioid,Abuse, Prescription Opioid,Addiction, Opiate,Dependence, Opiate,Disorder, Opioid Use,Misuse, Opioid,Misuse, Prescription Opioid,Opiate Abuses,Opioid Abuse, Prescription,Opioid Abuses,Opioid Addictions,Opioid Dependences,Opioid Misuses,Opioid Related Disorders,Opioid Use Disorders,Opioid-Related Disorder,Prescription Opioid Abuses,Prescription Opioid Misuses
D004637 Emergency Services, Psychiatric Organized services to provide immediate psychiatric care to patients with acute psychological disturbances. Emergency Psychiatric Services,Psychiatric Emergency Services,Services, Emergency Psychiatric,Services, Psychiatric Emergency,Emergency Psychiatric Service,Emergency Service, Psychiatric,Psychiatric Emergency Service,Psychiatric Service, Emergency,Psychiatric Services, Emergency,Service, Emergency Psychiatric,Service, Psychiatric Emergency
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

N Loimer, and P Hofmann, and H R Chaudhry
Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
January 1989, Journal of psychiatric research,
N Loimer, and P Hofmann, and H R Chaudhry
Naloxone challenge as a biological predictor of treatment outcome in opiate addicts.
January 1989, The American journal of drug and alcohol abuse,
N Loimer, and P Hofmann, and H R Chaudhry
Is subcutaneous or intramuscular naloxone as effective as intravenous naloxone in the treatment of life-threatening heroin overdose?
May 2002, The Medical journal of Australia,
N Loimer, and P Hofmann, and H R Chaudhry
Intravenous opiate maintenance in a cohort of injecting drug addicts.
March 2003, Drug and alcohol dependence,
N Loimer, and P Hofmann, and H R Chaudhry
[Changes in route of drug administration in heroin addicts].
October 1993, Revista clinica espanola,
N Loimer, and P Hofmann, and H R Chaudhry
Brief effective treatment strategies: pharmacological therapy for opiate addicts.
January 1985, NIDA research monograph,
N Loimer, and P Hofmann, and H R Chaudhry
The nasal route for drug administration.
March 1991, Hospital practice (Office ed.),
N Loimer, and P Hofmann, and H R Chaudhry
Take home naloxone for opiate addicts. Big conclusions are drawn from little evidence.
October 2001, BMJ (Clinical research ed.),
N Loimer, and P Hofmann, and H R Chaudhry
Methotrexate treatment in cutaneous lupus erythematosus: subcutaneous application is as effective as intravenous administration.
October 2006, The British journal of dermatology,
N Loimer, and P Hofmann, and H R Chaudhry
Oral versus intravenous calcitriol: is the route of administration really important?
July 1995, Current opinion in nephrology and hypertension,
Copied contents to your clipboard!